Abstract:
PURPOSE:Certain subsets of patients have an increased risk of all-cause mortality when androgen deprivation therapy (ADT) is used with definitive radiotherapy. We evaluated the relationship between pretreatment serum testosterone, age, and comorbidities on survival after prostate brachytherapy in men treated with and without ADT. METHODS AND MATERIALS:From October 2001 to September 2005, 803 patients underwent brachytherapy and 720 had a pretreatment serum testosterone. Comorbidities were prospectively recorded for each patient (body mass index>30, hypertension, diabetes, current smoker). Median followup was 5.0 years. 34.2% of the patients received ADT. Focus was on subset of men who might be expected to have more significant side effects associated with ADT. RESULTS:ADT did not significantly impact overall survival (OS) in men <65 years, >65 years, with one or no comorbidities, with more than one comorbidity, or with normal/high testosterone level. ADT use in men with low testosterone level was associated with decreased OS (83.6% vs. 93.1%, p=0.01). The adverse impact of ADT in men with low testosterone level was restricted to men with low testosterone level and more than one comorbidity (OS of 71.3% vs. 92.8%, p<0.01), with death from cardiovascular diseases accounting for almost all of the excess mortality. The subset of men with multiple comorbidities and normal/high testosterone level did not experience adverse OS with ADT. CONCLUSIONS:Low pretreatment testosterone level may be a marker for men at increased risk of premature death with ADT. The combination of low pretreatment serum testosterone level and multiple preexisting comorbidities is associated with decreased OS when ADT is incorporated into treatment.
journal_name
Brachytherapyjournal_title
Brachytherapyauthors
Taira AV,Merrick GS,Galbreath RW,Butler WM,Wallner KEdoi
10.1016/j.brachy.2009.06.008subject
Has Abstractpub_date
2010-01-01 00:00:00pages
42-9issue
1eissn
1538-4721issn
1873-1449pii
S1538-4721(09)00281-5journal_volume
9pub_type
杂志文章相关文献
Brachytherapy文献大全abstract:PURPOSE:The American Brachytherapy Society (ABS) consensus guidelines for high-dose-rate (HDR) prostate brachytherapy suggest 11 different dose constraints for the urethra. The purpose of this study is to evaluate whether a single urethral constraint of D0.1 cm3 < 110% could meet all the proposed ABS urethral constrain...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2019.12.001
更新日期:2020-01-01 00:00:00
abstract:PURPOSE:To investigate Axxent (iCAD, Inc., San Jose, CA) electronic brachytherapy balloon deformation and its dosimetric impact because of an external flexible shield (FlexiShield [FS]; iCAD, Inc.). METHODS AND MATERIALS:Prostheses breast tissue phantom overlaid three spherical balloon applicators to simulate three cl...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2017.01.009
更新日期:2017-01-01 00:00:00
abstract:PURPOSE:To assess the feasibility and tumor outcome of re-irradiation with low-dose-rate brachytherapy for macroscopic local recurrences after radical prostatectomy (RP) followed by adjuvant or salvage external beam radiation therapy (EBRT). METHODS AND MATERIALS:Between 2011 and 2018, five men with histologically pro...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2020.07.001
更新日期:2021-01-01 00:00:00
abstract:PURPOSE:To evaluate the long-term disease control and toxicity to the organs at risk after dose-escalated image-based adaptive brachytherapy (BT) in cervical cancer. METHODS AND MATERIALS:Sixty patients of cervical cancer were treated with external radiotherapy 46 Gy in 23 fractions with weekly cisplatin and MRI-guide...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2017.09.008
更新日期:2018-01-01 00:00:00
abstract:PURPOSE:Accelerated partial breast irradiation (APBI) continues to increase in popularity. Up to 14% of patients treated with the MammoSite (MS) report some degree of chronic pain, which may be related to chest wall toxicity. Reports from several institutions using the multicatheter (MC) technique have not shown associ...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2008.11.007
更新日期:2009-04-01 00:00:00
abstract:PURPOSE:To compare a standard radio-oncological and a surgical biochemical failure definition after combined-modality radiation therapy (CRT) in men with intermediate- and high-risk prostate cancer. METHODS:425 men were treated with external beam radiotherapy (59.4 Gy, 33 fractions) and 125J seed-brachytherapy (S-BT, ...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2019.09.001
更新日期:2020-01-01 00:00:00
abstract:PURPOSE:To evaluate outcomes after exclusive salvage high-dose-rate (HDR) intraluminal esophageal brachytherapy given to previously irradiated patients with recurrent esophageal cancer. METHODS AND MATERIALS:We reviewed medical records of 30 patients who were treated by salvage HDR brachytherapy for local esophageal c...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2015.02.392
更新日期:2015-07-01 00:00:00
abstract:PURPOSE:The British Columbia Cancer Agency has been performing iodine-125 prostate brachytherapy since 1998, initially using loose seeds and phasing into the exclusive use of RAPIDStrand (RS) (Oncura Inc., Plymouth Meeting, PA) by November 2000. The aim of this study was to investigate rates of biochemical no evidence ...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2011.01.011
更新日期:2011-11-01 00:00:00
abstract:PURPOSE:To describe in detail British Columbia (BC) Cancer Agency (BCCA) Provincial Prostate Brachytherapy (PB) Quality Assurance (QA) Program. METHODS AND MATERIALS:The BCCA PB Program was established in 1997. It operates as one system, unified and supported by electronic and information systems, making it a single P...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2012.03.006
更新日期:2013-07-01 00:00:00
abstract:OBJECTIVE:To determine the usefulness of prostate-specific antigen (PSA) percentage (vs. pretreatment value assumed as 100%) in prediction of biochemical relapse, after iodine-125 ((125)I) permanent brachytherapy for prostate cancer, to employ a parameter independent by the initial PSA amount and by the individual pros...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2011.08.008
更新日期:2012-07-01 00:00:00
abstract:PURPOSE:To identify patients at extremely low risk of biochemical recurrence (BCR) of prostate cancer after low-dose-rate brachytherapy (LDR-BT) to determine when prostate-specific antigen (PSA) monitoring can be stopped. METHODS AND MATERIALS:We retrospectively reviewed clinicopathologic data of patients with prostat...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2018.08.018
更新日期:2018-01-01 00:00:00
abstract:PURPOSE:HDRILBT is one of the best methods of palliation for advanced esophageal cancer (AEC) by improving dysphagia-free survival (DFS) and overall survival (OS). This study examines if the addition of EBRT would further improve the outcome by improving DFS in AEC. METHODS AND MATERIALS:Patients with inoperable AEC w...
journal_title:Brachytherapy
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/j.brachy.2004.09.004
更新日期:2004-01-01 00:00:00
abstract:PURPOSE:To report the preliminary results of transabdominal ultrasound (TAUS)-guided brachytherapy (BT) in cervical cancer. METHODS AND MATERIALS:Twenty-nine patients with cervical cancer Stage IB-IVA according to The International Federation of Gynecology and Obstetrics staging were treated by radical radiotherapy fr...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2014.11.001
更新日期:2015-03-01 00:00:00
abstract:BACKGROUND:Cervical cancer patients are faced with an enormous amount of medical information in a complex oncology field with sophisticated treatments including brachytherapy. We investigated the use of enhanced vs. standard brachytherapy-specific educational materials on patient-reported satisfaction during the inform...
journal_title:Brachytherapy
pub_type: 杂志文章,随机对照试验
doi:10.1016/j.brachy.2015.09.007
更新日期:2016-01-01 00:00:00
abstract:PURPOSE:To evaluate lumpectomy followed by interstitial brachytherapy as an acceptable salvage therapy for women who have developed localized recurrence of breast cancer after conservation surgery and postoperative external radiotherapy. METHODS AND MATERIALS:Between 1/1998 and 10/2006, 21 patients with T0 or T1 in-br...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2007.12.001
更新日期:2008-01-01 00:00:00
abstract:PURPOSE:The purpose of this study was to evaluate the incidence of late severe (≥Grade 3) urinary toxicity and the long-term efficacy after low-dose-rate brachytherapy (LDR-BT) in patients with localized prostate cancer (PCa). METHODS AND MATERIALS:During the years 1999-2008, 241 patients with PCa who underwent LDR-BT...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2019.05.005
更新日期:2019-01-01 00:00:00
abstract:PURPOSE:Marriage has been associated with enhanced survival among cancer patients, but conflicting correlations have been suggested in cervical cancer. We assessed the impact of marital status on receipt of brachytherapy and survival in women with locally advanced cervical cancer. METHODS AND MATERIALS:Three thousand,...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2019.04.273
更新日期:2019-01-01 00:00:00
abstract:UNLABELLED:PURPOSE/INTRODUCTION: To safely irradiate retroperitoneal targets as paraaortic lymph node by separating abdominal at-risk organs from the target during irradiation, we created a percutaneous paravertebral approach of high-dose-rate brachytherapy with hyaluronate gel injection (HGI). We report a case treated...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2011.12.004
更新日期:2013-01-01 00:00:00
abstract:PURPOSE:To assess the impact of experience and technical changes on morbidity during the first year after permanent prostate brachytherapy. METHODS AND MATERIALS:From July 2003 to May 2010, 150 patients with prostate cancer underwent low-dose iodine-125 prostate brachytherapy as a monotherapy by the same medical team ...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2013.04.002
更新日期:2013-11-01 00:00:00
abstract:PURPOSE:To investigate the safety and feasibility of intraluminal brachytherapy using 125I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice. METHODS AND MATERIALS:From January 2010 to February 2015, 18 consecutive patients diagnosed with locally advanced, nonmetastatic, inope...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2016.05.004
更新日期:2016-01-01 00:00:00
abstract:PURPOSE:In this planning study, we investigated the dosimetric benefit of repeat CT-based treatment planning at each fraction vs. the use of a single CT-based treatment plan for all fractions for high-dose-rate endorectal brachytherapy (HDREBT) for rectal cancer. METHODS AND MATERIALS:We included 11 patients that rece...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2017.08.011
更新日期:2018-01-01 00:00:00
abstract:PURPOSE:The purpose of this study was to prospectively assess the variations in health-related quality of life (HR-QoL) in patients who underwent low-dose rate prostate brachytherapy using iodine-125 seed source during the first year after seed implantation. METHODS AND MATERIALS:Between July 2004 and December 2006, 1...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2009.07.013
更新日期:2010-10-01 00:00:00
abstract:BACKGROUND:To determine the feasibility of combined perioperative high-dose-rate brachytherapy (PHDRB) and intermediate-dose external beam radiation therapy (EBRT) as an alternative to full-dose adjuvant EBRT in patients with unirradiated squamous cell cancer (SCC) of the oral cavity and oropharynx. METHODS AND MATERI...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2008.10.002
更新日期:2009-01-01 00:00:00
abstract:PURPOSE:We sought to develop an activity nomogram for magnetic resonance (MR)-planned permanent seed prostate brachytherapy to improve quality assurance through a secondary dosimetric check. METHODS AND MATERIALS:Patients undergoing MRI-assisted radiosurgery (MARS), whereby MRI is used for preoperative planning and po...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2019.10.002
更新日期:2020-01-01 00:00:00
abstract:PURPOSE:To present recommendations for the use of brachytherapy (BT) in patients with soft tissue sarcoma (STS). METHODS:A group of practitioners with expertise and experience in sarcoma BT formulated recommendations for BT in STS based on clinical experience and literature review. RESULTS:The indications for adjuvan...
journal_title:Brachytherapy
pub_type: 杂志文章,评审
doi:10.1016/j.brachy.2012.12.002
更新日期:2013-05-01 00:00:00
abstract:PURPOSE:Dose escalation has been shown beneficial in prostate cancer. Brachytherapy (BT) provides an opportunity for dose escalation beyond what can be safely delivered using only teletherapy methods. The purpose of this study was to determine cancer control and morbidity of external beam radiation therapy (EBRT) plus ...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2009.01.002
更新日期:2009-04-01 00:00:00
abstract:PURPOSE:To explore the dosimetric advantage of target volume and surrounding normal tissue by using interstitial (IS) brachytherapy (BT) based on three-dimensional CT in locally advanced cervical cancer, as a simple and effective clinical treatment approach. METHODS AND MATERIALS:Fifty-two patients with poor tumor res...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2016.06.004
更新日期:2016-09-01 00:00:00
abstract::A 17-year-old girl diagnosed with a previously irradiated, locally recurrent Ewing's sarcoma involving the puboischiatic rami and the adjacent acetabulum was referred to our institution for consideration of salvage hindquarter resection. A conservative resection with implantation of the acetabular remnant for high-dos...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/S1538-4721(03)00098-9
更新日期:2003-01-01 00:00:00
abstract:PURPOSE:To assess the difference in prostate-specific antigen (PSA) response kinetics in patients undergoing either (125)I or (103)Pd permanent prostate brachytherapy (PPB). METHODS AND MATERIALS:Between 1997 and 1999, 333 patients underwent PPB as monotherapy. Forty-eight patients received a (125)I implant, and 285 r...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/S1538-4721(03)00004-7
更新日期:2003-01-01 00:00:00
abstract:OBJECTIVE:To compare dosimetrically the stereotactic CyberKnife (CK) therapy and multicatheter high-dose-rate (HDR) brachytherapy (BT) for accelerated partial breast irradiation (APBI). METHODS:Treatment plans of 25 patients treated with CK were selected, and additional plans using multicatheter HDR BT were created on...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2020.10.003
更新日期:2020-11-18 00:00:00